Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 10 Results

Title
Intervention Indication Therapeutic Area Year Actions
Apremilast for treating moderate to severe plaque psoriasis in children and young people Apremilast (Otezla; CC-10004) Plaque psoriasis Dermatology 2023 View  |  Download
Bimekizumab for moderate to severe chronic plaque psoriasis Bimekizumab (UCB4940) Plaque psoriasis Dermatology 2019 View  |  Download
BMS-986165 for moderate to severe plaque psoriasis Deucravacitinib (BMS-986165) Plaque psoriasis Dermatology 2020 View  |  Download
Certolizumab pegol (Cimzia) for chronic plaque psoriasis in adults Certolizumab (CDP-870; Cimzia; certolizumab pegol) Plaque psoriasis Dermatology 2017 View  |  Download
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years Guselkumab (Tremfya; CNTO-1959) Plaque psoriasis Dermatology 2024 View  |  Download
Risankizumab (by Subcutaneous Injection) for Moderate to Severe Chronic Plaque Psoriasis Risankizumab (BI 655066; Skyrizi; ABBV 066) Plaque psoriasis Dermatology 2017 View  |  Download
Secukinumab biosimilar for treating plaque psoriasis Secukinumab biosimilar (BAT2306) Plaque psoriasis Dermatology 2024 View  |  Download
Secukinumab for moderate to severe plaque psoriasis in children aged 6 to less than 18 years old Secukinumab (Cosentyx; AIN457) Plaque psoriasis Dermatology 2019 View  |  Download
Ustekinumab biosimilar for Plaque psoriasis Ustekinumab biosimilar (ONS3040; FYB202; CT-P43; BAT2206; DMB-3115; SB17; Bmab 1200; AVT04; ABP654) Plaque psoriasis Dermatology 2022 View  |  Download
Ustekinumab biosimilar for treating moderate to severe plaque psoriasis Ustekinumab biosimilar (ONS3040; FYB202; CT-P43; BAT2206; DMB-3115; SB17; Bmab 1200; AVT04; ABP654) Plaque psoriasis Dermatology 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications